id
name
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2023-12-26 11:32:23
expired found date
-
created at
2024-06-21 02:59:44
updated at
2026-01-22 10:25:58
length
10
crc
54164
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
-
server bits
—
server ip
-
mp import status
20
mp rejected date
-
mp saved date
-
mp size orig
406140
mp size raw text
2855
mp inner links count
7
mp inner links status
20 (imported)
title
Takeda Pharmaceuticals: Global Homepage
description
Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
site name
author
updated
2025-12-30 13:24:47
raw text
Takeda Pharmaceuticals: Global Homepage Search... GLOBAL | Takeda Pharmaceuticals: Global Homepage This new building produces more energy than it uses Learn More We exist to create better health for people and a brighter future for the world. While the science and technology we advance are constantly evolving, our ambition remains. We move science forward, so we can transform more lives. Recent News U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Ulcerative Colitis September 27, 2023 Takeda Announces Approval of CUVITRU Subcutaneous Immunoglobulin in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia September 25, 2023 Takeda Announces FDA Acceptance of NDA Resubmission of TAK-721 (budesonide oral suspension) for the Short-Term Treatment of Eosinophilic Esophagitis (EoE) September 20, 2023 Takeda Commits Over $30 Million in Five New Global CSR Partner...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
Medicine [en] (226)
index version
2025123101
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
2311
text words
380
text unique words
231
text lines
55
text sentences
13
text paragraphs
5
text words per sentence
29
text matched phrases
2
text matched dictionaries
5
links self subdomains
0
links other subdomains
links other domains
2 - takeda.info
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
2 - linkedin.com, youtube.com
links ext klim
0
links ext generic
0
dol status
0
dol updated
2025-12-30 13:24:47
rss path
rss status
1 (priority 1 already searched, no matches found)
rss found date
-
rss size orig
0
rss items
0
rss spam phrases
0
rss detected language
0 (awaiting analysis)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
30 (processing completed, results pushed to table crawler_sitemaps.ext_domain_sitemap_lists)
sitemap review version
2
sitemap urls count
8095
sitemap urls adult
0
sitemap filtered products
46
sitemap filtered videos
0
sitemap found date
2023-12-26 11:32:23
sitemap process date
2026-01-15 21:10:38
sitemap first import date
-
sitemap last import date
-